Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

ILC1 cells contribute to hair loss in alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Ginseng and Albizia extracts may help prevent age-related hair thinning.

Blue light can help hair grow by affecting certain receptors in hair follicles.

miR-486 may help prevent hair loss in alopecia areata.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Abatacept may help some people with alopecia areata regrow hair.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Mitochondrial stress can lead to atopic dermatitis.